News
![NICE Actimize Positioned as a Leading KYC Vendor in 2021 Quadrant Knowledge Report Across Technology Excellence and Customer Impact : https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtvRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--06f22a0c3a8fabdec4f231cf3ebdea0279feec53/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NICE_inContact.jpg?locale=us)
NICE Actimize Positioned as a Leading KYC Vendor in 2021 Quadrant Knowledge Report Across Technology Excellence and Customer Impact
NICE Actimize, a NICE (Nasdaq: NICE) business, has been ranked by global advisory and consulting firm Quadrant Knowledge Solutions as a top performing KYC/CDD Technology Leader in its recently
![NanoString to Webcast Presentation from the UBS Global Healthcare Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzhpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6ef578a6eaa604de21c95a83c7b989a1a3263c9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NSTG-Logo-19--28002-29.jpg?locale=us)
NanoString to Webcast Presentation from the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a
![Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-19 vaccine
![SES Successfully Prices EUR 625 Million Hybrid Bond Offering](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
SES Successfully Prices EUR 625 Million Hybrid Bond Offering
SES S.A. announced the successful launch and pricing of a hybrid bond offering in which it has agreed to sell Deeply Subordinated Fixed Rate Resettable Securities for a total amount of EUR 625
![ADVA provides simple, cost-efficient route to 10G services with new edge solution](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
ADVA provides simple, cost-efficient route to 10G services with new edge solution
ADVA (FSE: ADV) today launched its new compact, low-power edge demarcation solution, giving network operators an easy and cost-efficient route to 10Gbit/s Carrier Ethernet services. The ADVA FSP
![Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual Meeting: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTRqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8c255f1cb7b73806f677f1d1d64e93866d2979a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Clovis_Logo_Process_Color.jpg?locale=us)
Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual Meeting
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that four abstracts featuring data from clinical studies evaluating Rubraca and/or lucitanib and one abstract on real world data of PARP
![CORRECTING and REPLACING Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical Oncology](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
CORRECTING and REPLACING Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical Oncology
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210519005957/en/
Please replace the release dated May 19, 2021 with
![Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2021 ASCO Annual Meeting : https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN29sRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2c39f3b6129a12541932c63b90c23307b141ad6b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/puma_logo_JPEG.jpg?locale=us)
Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2021 ASCO Annual Meeting
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced publication of three abstracts on neratinib for the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
![Copart Reports Third Quarter Fiscal 2021 Financial Results](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Copart Reports Third Quarter Fiscal 2021 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended April 30, 2021.
For the three months ended April 30, 2021, revenue, gross profit, and net income were $733.9
State Street Corporation Declares Second-Quarter Dividend on its Common Stock
State Street Corporation (NYSE: STT) today announced a quarterly cash dividend of $0.52 per share of common stock, payable on July 12, 2021 to common shareholders of record at the close of business
![Investors Title Company Declares Quarterly Dividend: https://mms.businesswire.com/media/20191104005086/en/753735/5/Investors_Title-logo-tagline.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--272cbc1dbac28e15b2c6d1380d7581eecf49f2ce/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Investors_Title-logo-tagline.jpg?locale=us)
Investors Title Company Declares Quarterly Dividend
Investors Title Company (Nasdaq: ITIC) announced today that the Company's Board of Directors has declared a cash dividend of $.46 per share to shareholders of record June 15, 2021, payable June 30
![Innovative Industrial Properties Prices Private Offering of 5.50% Senior Notes Due 2026](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Innovative Industrial Properties Prices Private Offering of 5.50% Senior Notes Due 2026
Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today that its operating partnership, IIP Operating Partnership, LP (the “Operating Partnership”), priced a private
![Donnell A. Segalas Concludes his Service as a Member of the Board of Annaly Capital Management, Inc.: https://mms.businesswire.com/media/20191107006051/en/722862/5/Annaly_Blue.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1FpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b19d43ddf63abe94ed98ff8737b86c51234a4bb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Annaly_Blue.jpg?locale=us)
Donnell A. Segalas Concludes his Service as a Member of the Board of Annaly Capital Management, Inc.
Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) announced today that director Donnell A. Segalas stepped down from the Company’s Board of Directors (the “Board”) upon the
![Keysight Technologies Reports Second Quarter 2021 Results: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1VqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bca68eb5e804e1802db2e2b6ef512db960c90ff6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Keysight_Signature_Pref_Color.jpg?locale=us)
Keysight Technologies Reports Second Quarter 2021 Results
Keysight Technologies, Inc. (NYSE: KEYS) today reported financial results for the second fiscal quarter of 2021 ended April 30, 2021.
“Keysight delivered an exceptional quarter and achieved
![Semtech Announces First Quarter Fiscal Year 2022 Conference Call: https://mms.businesswire.com/media/20191106005365/en/1659/5/Semtech_stack_color_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0FrRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3eab404c2b67e081278e6e848e75dc77dace506f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Semtech_stack_color_logo.jpg?locale=us)
Semtech Announces First Quarter Fiscal Year 2022 Conference Call
Semtech Corporation (NASDAQ: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, today announced plans to release the financial results of
Brown-Forman Fourth Quarter Earnings Release and Conference Call Scheduled for June 9, 2021
Brown-Forman Corporation (NYSE:BFA) (NYSE:BFB) will release its financial results for the fourth quarter and fiscal year 2021 on June 9, 2021 by 8:00 a.m. (EDT), followed by a conference call to
![Agilent Announces Cash Dividend of 19.4 Cents per Share](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on July 28, 2021, to all shareholders of record as of the close
![Xcel Energy Inc. Board Declares Dividend on Common Stock: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24841/Xcel_Energy.JPG](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaFlCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b533b42f5e5d3878ccf0fff14014a4ca8c3f814b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Xcel_EnergyJPG.png?locale=us)
Xcel Energy Inc. Board Declares Dividend on Common Stock
The Board of Directors of Xcel Energy Inc. (NASDAQ: XEL) today declared a quarterly dividend on its common stock of 45.75 cents per share. The dividends are payable July 20, 2021, to shareholders
![REX American Resources to Report Fiscal 2021 Q1 Results and Host Conference Call and Webcast on Wednesday, May 26: https://mms.businesswire.com/media/20191126005542/en/5893/5/Rex_Logo_3-02.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1d4RXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0bb69078bdf3f7a5ad7eab0f75645c60c8b4a77f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Rex_Logo_3-02.jpg?locale=us)
REX American Resources to Report Fiscal 2021 Q1 Results and Host Conference Call and Webcast on Wednesday, May 26
REX American Resources Corporation (NYSE American: REX), a leading ethanol company, announced today that it will report its fiscal 2021 first quarter financial results on Wednesday, May 26
![MND : 2020/2021 half-year results - Outlook for second-half 2020/2021](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
MND : 2020/2021 half-year results - Outlook for second-half 2020/2021
2020/2021 half-year results
Solid resilience in activity, decline limited to -5%
Operational break-even target (adjusted EBITDA) achieved in H1
Outlook for second-half 2020/2021
Sustained business
![Cubic and MTC Bring Digital Fare Payments to Android Users](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Cubic and MTC Bring Digital Fare Payments to Android Users
Cubic Corporation (NYSE:CUB) today announced its Cubic Transportation Systems (CTS) business division and the Metropolitan Transportation Commission (MTC) launched mobile fare payments on
![Quantum Genomics Announces the Publication of New Scientific Article in Biomedecine et Pharmacotherapy which further strengthen its Phase III development plan in difficult to treat and resistant hypertension](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Quantum Genomics Announces the Publication of New Scientific Article in Biomedecine et Pharmacotherapy which further strengthen its Phase III development plan in difficult to treat and resistant hypertension
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat difficult to
![Valbiotis Obtains Patent for Its Active Substance TOTUM•63 in China, a Large Potential Market for the Prevention of Type 2 Diabetes and Metabolic Diseases: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXFzSVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--15bfdf03f8ab493929a3d2392e314697d3469f59/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/valbiotis-logo.jpg?locale=us)
Valbiotis Obtains Patent for Its Active Substance TOTUM•63 in China, a Large Potential Market for the Prevention of Type 2 Diabetes and Metabolic Diseases
Regulatory News:
Valbiotis (FR0013254851 - ALVAL, eligible for the PEA / SME), a Research and Development company committed to scientific innovation for preventing and combating metabolic
![ECS Named #1 on ChannelE2E Top 100 Vertical Market MSPs 2021 List: https://mms.businesswire.com/media/20191107005504/en/656931/5/ECS_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDhpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--49091f42ab31b3bbdd9e90672722bf57263c3ebc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ECS_Logo.jpg?locale=us)
ECS Named #1 on ChannelE2E Top 100 Vertical Market MSPs 2021 List
ECS, a leading provider of advanced technology, science, and engineering solutions has been named the #1 top government managed-service provider (MSP) for the third year in a row on After Nines
![AGROGENERATION : General Meeting to be held behind closes doors on June 24, 2021](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
AGROGENERATION : General Meeting to be held behind closes doors on June 24, 2021
Paris, May 19th, 2021
Amid the ongoing COVID-19 epidemic and in line with government measures to slow the spread of the virus and the provisions of Decree No. 2021-255 of March 9, 2021, the